Splice variant expression of CD44 in patients with breast and ovarian cancer

Oncology Reports

Volumn 8, Issue 1, 2001, Pages 145-151

  Hajos, S E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Breast cancer; CD44; CD44 isoforms; Ovarian cancer; RT PCR

Indexed keywords

HERMES ANTIGEN; ISOPROTEIN; MESSENGER RNA; RNA; TUMOR ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ALTERNATIVE RNA SPLICING; ARTICLE; BIOSYNTHESIS; BREAST PAPILLOMA; BREAST TUMOR; CELL ADHESION; CHEMISTRY; EXON; FEMALE; FIBROADENOMA; GENETICS; HUMAN; OVARY TUMOR; PAGET NIPPLE DISEASE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ALTERNATIVE SPLICING; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION; EXONS; FEMALE; FIBROADENOMA; HUMANS; OVARIAN NEOPLASMS; PAPILLOMA, INTRADUCTAL; PROGNOSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0035227133     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Stauder R and Gunthert U: CD44 isoforms. Impact on lymphocyte activation and differentiation. The Immunologist 3: 78-83, 1995.
2. Mackay CR, Terpe HJ, Stauder R, Marston W, Stark H and Gunthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71-82, 1994.